Role of calcium-channel blockers in obstructive airway disease.
T
T
Ahmed
W M
WM
Abraham
D000109:Acetylcholine / Q000037:antagonists & inhibitors; D000818:Animals; D001249:Asthma / Q000188:drug therapy / Q000276:immunology / Q000378:metabolism / Q000503:physiopathology; D001250:Asthma, Exercise-Induced / Q000517:prevention & control; D002118:Calcium / Q000502:physiology; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D004110:Diltiazem / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004573:Electrolytes / Q000378:metabolism; D006023:Glycoproteins / Q000378:metabolism; D006636:Histamine Release / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D007473:Ion Channels; D008173:Lung Diseases, Obstructive / Q000188:drug therapy / Q000503:physiopathology*; D008407:Mast Cells / Q000187:drug effects / Q000378:metabolism; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000378:metabolism; D009543:Nifedipine / Q000494:pharmacology; D012119:Respiration / Q000187:drug effects; D012137:Respiratory System / Q000378:metabolism; D014700:Verapamil / Q000494:pharmacology
D002121:Calcium Channel Blockers; D004573:Electrolytes; D006023:Glycoproteins; D007473:Ion Channels; D014700:Verapamil; D004110:Diltiazem; D009543:Nifedipine; D000109:Acetylcholine; D002118:Calcium